Form 4 Filing for Milmoe William H. - Integrated Biopharma Inc.

This filing details a Form 4 submission by William H. Milmoe, a director at Integrated Biopharma Inc. (INBP). On June 24, 2026, Mr. Milmoe acquired 50,000 stock options with a right to buy underlying Common Stock. The transaction code indicates an acquisition, and the ownership is direct. These options have an exercise price of $0.19 per share and an expiration date of June 24, 2036. The acquired options will vest in four equal installments, with the first installment vesting on September 30, 2026, and the final installment on June 30, 2027. Following this transaction, Mr. Milmoe directly owns 50,000 shares, all of which are in the form of stock options.